Feed Top Reports Pricing

⌘K

09:35:15·37d

INSIDERFiling

SEC Form 3 filed by Mesoblast Limited

MESO· Mesoblast Limited

Health Care

Full content unavailable. See the original source below.

Original source

Companies

MESO
Mesoblast Limited
Health Care

Recent analyst ratings

Nov 25UpdateJefferies-
Jul 18UpdateJefferies-
Dec 23UpdateJefferies-
Sep 24UpdateMaxim Group$12.00
Aug 29UpdateJefferies-
Jul 23UpdatePiper Sandler$11.00

Related

SEC7d
SEC Form 6-K filed by Mesoblast Limited
SEC9d
SEC Form 6-K filed by Mesoblast Limited
PR9d
Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products
INSIDER11d
SEC Form 4 filed by George Gregory
INSIDER13d
SEC Form 4 filed by George Gregory
PR13d
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION
PR16d
Mesoblast R&D Day Features Significant Commercial Progress & Platform Innovation
SEC16d
SEC Form 6-K filed by Mesoblast Limited

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022